Market Overview:
According to IMARC Group’s latest research publication, “Oncology Information Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033“, The global oncology information systems market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.95% during 2025-2033.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
How AI is Reshaping the Future of Oncology Information Systems Market
- AI enhances cancer diagnosis accuracy through deep learning models analyzing medical imaging, with studies showing 44% reduction in radiologist workload while maintaining comparable clinical performance metrics in mammography screening.
- Machine learning algorithms enable personalized treatment planning by analyzing multi-dimensional data including genomics, pathology, and electronic health records, supporting precision oncology approaches tailored to individual patients.
- Healthcare organizations leverage AI-powered clinical decision-support systems that integrate patient data, lab results, pathology, imaging, and genomics to generate evidence-based treatment recommendations for physicians.
- AI-driven platforms like India’s iOncology.ai, launched in 2024, use deep learning to analyze radiological and histopathological images with high precision, trained on 500,000 images from 1,500 patient cases for early cancer detection.
- Integration of AI with oncology information systems reduces administrative burdens by automating data analysis, treatment outcome prediction, and clinical trial recruitment, enabling clinicians to focus on patient care delivery.
Download a sample PDF of this report: https://www.imarcgroup.com/oncology-information-systems-market/requestsample
Key Trends in the Oncology Information Systems Market
- Rising Cancer Burden Drives OIS Adoption: Global cancer incidence reached 19.29 million cases in 2020 and is projected to hit 28.4 million by 2040, a 47% increase. In the US alone, over 2 million new cases were diagnosed in 2024, necessitating robust data management systems for patient information and treatment planning.
- Cloud-Based Solutions Gaining Momentum: Healthcare providers increasingly shift to cloud-based oncology information systems for enhanced accessibility, scalability, and cost-effectiveness. Major vendors like Elekta introduced cloud-integrated platforms in 2024 with real-time imaging analytics capabilities.
- Integration with Electronic Health Records: Seamless integration of OIS with hospital EHR systems streamlines workflows, reduces medical errors, and decreases clinical documentation time. Epic and Cerner have developed oncology-specific EHRs with advanced data analytics and visualization capabilities.
- Precision Medicine and Genomic Integration: Growing adoption of Next-Generation Sequencing (NGS) and biomarker analyses enables precise identification of actionable targets. OIS platforms now incorporate genomic data, multimodal fusion capabilities, and molecular pathway analysis for personalized treatment strategies.
- Remote Monitoring and Telemedicine Expansion: The RECOVER project launched AI-driven remote monitoring systems in February 2025 for gastrointestinal cancer patients, enabling early complication detection and improved care coordination, reflecting the shift toward digital health solutions post-pandemic.
Growth Factors in the Oncology Information Systems Market
- Increasing Healthcare IT Investment: Government and private sector investments in healthcare digitalization accelerate OIS adoption. The US healthcare IT market is projected to reach $821.1 billion by 2026, supporting integrated environments that address oncology care gaps.
- Regulatory Compliance Requirements: Stricter data privacy regulations and reporting requirements drive healthcare organizations to implement robust OIS platforms. The National Digital Health Blueprint in India and similar initiatives globally mandate ethical AI use and data security standards.
- Value-Based Care Transition: Healthcare systems shifting from fee-for-service to value-based models require comprehensive data management solutions. OIS enables real-time monitoring of treatment outcomes, patient engagement, and cost-effectiveness analysis supporting this transition.
- Rising R&D Activities: Increased funding in oncology research, with the US government investing $245 billion in medical R&D in 2020 (11% increase), fuels demand for sophisticated data management and clinical trial support systems that OIS provides.
- Workforce Optimization Needs: Growing shortage of healthcare IT professionals drives demand for automated, user-friendly OIS solutions. Professional services segment expands as healthcare facilities outsource software management to specialized vendors for efficient implementation and maintenance.
Leading Companies Operating in the Global Oncology Information Systems Industry:
- Accuray Incorporated
- Advanced Data Systems
- CureMD
- Elekta
- EndoSoft
- Koninklijke Philips N.V
- McKesson Corporation
- MICA Information Systems, Inc.
- Oracle Corporation
- Varian (Siemens Healthineers Company)
Oncology Information Systems Market Report Segmentation:
Breakup By Product and Services:
- Software
- Patient Information Systems
- Treatment Planning Systems
- Services
- Consulting Services
- Implementation Services
- Maintenance Services
Software accounts for the majority of shares on account of the rising need to streamline patient data and treatment planning capabilities.
Breakup By Application:
- Radiation Oncology
- Medical Oncology
- Surgical Oncology
Medical oncology dominates the market due to the high volume of cancer cases requiring comprehensive data management and treatment coordination.
Breakup By End User:
- Hospitals and Diagnostic Imaging Centers
- Ablation Care Centers and Cancer Care Centers
- Government Institutions
- Research Facilities
Hospitals and diagnostic imaging centers hold the largest share owing to extensive data generated during cancer diagnosis and treatment processes.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position owing to high cancer prevalence, advanced healthcare infrastructure, and widespread adoption of electronic health records systems.
Recent News and Developments in Oncology Information Systems Market
- February 2025: The RECOVER project launched an AI-driven remote monitoring system for gastrointestinal cancer patients in Europe, enabling early complication detection through real-time data analytics and improved care coordination between oncology teams.
- October 2024: Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI and OpenAI Service for processing unstructured oncology data, extracting actionable insights from complex clinical documents to support data-driven treatment planning.
- September 2025: Varian Medical Systems launched a cloud-based oncology information system in California, integrating treatment planning, EHR compatibility, and real-time analytics to enhance precision oncology and streamline clinical workflows across cancer centers.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
